annual operating expenses:
$8.14B+$1.07B(+15.16%)Summary
- As of today (August 23, 2025), REGN annual total operating expenses is $8.14 billion, with the most recent change of +$1.07 billion (+15.16%) on December 31, 2024.
- During the last 3 years, REGN annual operating expenses has risen by +$3.50 billion (+75.45%).
- REGN annual operating expenses is now at all-time high.
Performance
REGN Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$1.92B+$87.30M(+4.76%)Summary
- As of today (August 23, 2025), REGN quarterly total operating expenses is $1.92 billion, with the most recent change of +$87.30 million (+4.76%) on June 30, 2025.
- Over the past year, REGN quarterly operating expenses has increased by +$68.10 million (+3.68%).
- REGN quarterly operating expenses is now -7.26% below its all-time high of $2.07 billion, reached on December 31, 2024.
Performance
REGN quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
REGN Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.2% | +3.7% |
| 3 y3 years | +75.5% | +63.0% |
| 5 y5 years | +127.2% | +99.8% |
REGN Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.5% | -7.3% | +63.0% |
| 5 y | 5-year | at high | +127.2% | -7.3% | +128.4% |
| alltime | all time | at high | >+9999.0% | -7.3% | >+9999.0% |
REGN Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.92B(+4.8%) |
| Mar 2025 | - | $1.83B(-11.5%) |
| Dec 2024 | $8.14B(+15.2%) | $2.07B(+10.6%) |
| Sep 2024 | - | $1.87B(+1.1%) |
| Jun 2024 | - | $1.85B(+0.8%) |
| Mar 2024 | - | $1.84B(+4.8%) |
| Dec 2023 | $7.07B(+25.8%) | $1.75B(+9.0%) |
| Sep 2023 | - | $1.61B(-1.5%) |
| Jun 2023 | - | $1.63B(+2.0%) |
| Mar 2023 | - | $1.60B(+0.6%) |
| Dec 2022 | $5.62B(+21.1%) | $1.59B(+22.3%) |
| Sep 2022 | - | $1.30B(+10.5%) |
| Jun 2022 | - | $1.18B(-1.7%) |
| Mar 2022 | - | $1.20B(-4.4%) |
| Dec 2021 | $4.64B(+22.1%) | $1.25B(+16.3%) |
| Sep 2021 | - | $1.08B(+5.1%) |
| Jun 2021 | - | $1.03B(-1.4%) |
| Mar 2021 | - | $1.04B(+23.7%) |
| Dec 2020 | $3.80B(+6.1%) | $841.10M(-7.3%) |
| Sep 2020 | - | $907.60M(-5.6%) |
| Jun 2020 | - | $961.30M(+12.5%) |
| Mar 2020 | - | $854.70M(-6.3%) |
| Dec 2019 | $3.58B(+63.3%) | $911.80M(+25.5%) |
| Sep 2019 | - | $726.80M(-31.7%) |
| Jun 2019 | - | $1.06B(+59.0%) |
| Mar 2019 | - | $669.50M(-36.2%) |
| Dec 2018 | $2.19B(-35.4%) | $1.05B(+17.8%) |
| Sep 2018 | - | $890.76M(+3.5%) |
| Jun 2018 | - | $860.53M(+8.5%) |
| Mar 2018 | - | $793.00M(-12.2%) |
| Dec 2017 | $3.40B(+5.1%) | $903.39M(+13.1%) |
| Sep 2017 | - | $798.80M(+2.2%) |
| Jun 2017 | - | $781.76M(+2.0%) |
| Mar 2017 | - | $766.17M(-1.3%) |
| Dec 2016 | $3.23B(+31.3%) | $776.24M(-1.1%) |
| Sep 2016 | - | $785.25M(-5.0%) |
| Jun 2016 | - | $826.94M(+12.2%) |
| Mar 2016 | - | $736.81M(+0.5%) |
| Dec 2015 | $2.46B(+37.3%) | $733.25M(+19.2%) |
| Sep 2015 | - | $615.24M(+11.9%) |
| Jun 2015 | - | $549.62M(+13.1%) |
| Mar 2015 | - | $486.08M(+1.0%) |
| Dec 2014 | $1.79B(+48.4%) | $481.35M(+1.7%) |
| Sep 2014 | - | $473.47M(+23.3%) |
| Jun 2014 | - | $383.90M(-0.2%) |
| Mar 2014 | - | $384.70M(+13.5%) |
| Dec 2013 | $1.21B(+44.2%) | $338.93M(+9.0%) |
| Sep 2013 | - | $310.85M(+24.2%) |
| Jun 2013 | - | $250.22M(+0.8%) |
| Mar 2013 | - | $248.15M(+8.4%) |
| Dec 2012 | $836.31M(+29.3%) | $228.88M(+17.6%) |
| Sep 2012 | - | $194.65M(+5.7%) |
| Jun 2012 | - | $184.16M(-2.5%) |
| Mar 2012 | - | $188.87M(+19.9%) |
| Dec 2011 | $646.77M(+16.6%) | $157.46M(+3.2%) |
| Sep 2011 | - | $152.56M(-4.5%) |
| Jun 2011 | - | $159.83M(+9.6%) |
| Mar 2011 | - | $145.82M(+4.3%) |
| Dec 2010 | $554.45M(+22.8%) | $139.77M(+5.2%) |
| Sep 2010 | - | $132.81M(-1.4%) |
| Jun 2010 | - | $134.68M(+5.8%) |
| Mar 2010 | - | $127.29M(-2.7%) |
| Dec 2009 | $451.69M(+39.5%) | $130.89M(+14.1%) |
| Sep 2009 | - | $114.68M(+11.5%) |
| Jun 2009 | - | $102.86M(+15.6%) |
| Mar 2009 | - | $89.00M(+2.1%) |
| Dec 2008 | $323.78M | $87.18M(+5.7%) |
| Sep 2008 | - | $82.45M(+325.2%) |
| Jun 2008 | - | $19.39M(+21.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $15.91M(+37.9%) |
| Dec 2007 | $239.48M(+47.0%) | $11.53M(-70.2%) |
| Sep 2007 | - | $38.67M(+26.3%) |
| Jun 2007 | - | $30.60M(-9.0%) |
| Mar 2007 | - | $33.65M(-15.9%) |
| Dec 2006 | $162.96M(-340.4%) | $40.00M(+7.6%) |
| Sep 2006 | - | $37.16M(+1.0%) |
| Jun 2006 | - | $36.80M(+8.1%) |
| Mar 2006 | - | $34.06M(-12.0%) |
| Dec 2005 | -$67.78M(-144.3%) | $38.71M(-10.8%) |
| Sep 2005 | - | $43.40M(+0.9%) |
| Jun 2005 | - | $43.03M(+12.6%) |
| Mar 2005 | - | $38.20M(+687.1%) |
| Dec 2004 | $153.16M(+1.6%) | $4.85M(+16.0%) |
| Sep 2004 | - | $4.18M(-1.2%) |
| Jun 2004 | - | $4.24M(+11.7%) |
| Mar 2004 | - | $3.79M(-10.5%) |
| Dec 2003 | $150.81M(+9.7%) | $4.24M(+17.7%) |
| Sep 2003 | - | $3.60M(+3.2%) |
| Jun 2003 | - | $3.49M(+0.8%) |
| Mar 2003 | - | $3.46M(+2.0%) |
| Dec 2002 | $137.46M(+35.9%) | $3.39M(-11.0%) |
| Sep 2002 | - | $3.81M(+28.9%) |
| Jun 2002 | - | $2.96M(-13.1%) |
| Mar 2002 | - | $3.40M(+24.5%) |
| Dec 2001 | $101.15M(+46.6%) | $2.73M(+11.0%) |
| Sep 2001 | - | $2.46M(+3.3%) |
| Jun 2001 | - | $2.38M(+17.3%) |
| Mar 2001 | - | $2.03M(-28.4%) |
| Dec 2000 | $68.99M(+26.1%) | - |
| Sep 2000 | - | $2.84M(+65.8%) |
| Jun 2000 | - | $1.71M(-2.5%) |
| Mar 2000 | - | $1.75M(-39.5%) |
| Dec 1999 | $54.70M(+19.4%) | $2.90M(+124.0%) |
| Sep 1999 | - | $1.29M(-38.7%) |
| Jun 1999 | - | $2.11M(+236.7%) |
| Mar 1999 | - | $627.00K(-93.6%) |
| Dec 1998 | $45.80M(+20.5%) | $9.82M(+6.3%) |
| Sep 1998 | - | $9.24M(+341.7%) |
| Jun 1998 | - | $2.09M(+1.1%) |
| Mar 1998 | - | $2.07M(-77.7%) |
| Dec 1997 | $38.00M(-5.7%) | $9.30M(+1.1%) |
| Sep 1997 | - | $9.20M(-6.1%) |
| Jun 1997 | - | $9.80M(0.0%) |
| Mar 1997 | - | $9.80M(-1.0%) |
| Dec 1996 | $40.30M(+15.1%) | $9.90M(-6.6%) |
| Sep 1996 | - | $10.60M(+7.1%) |
| Jun 1996 | - | $9.90M(0.0%) |
| Mar 1996 | - | $9.90M(+16.5%) |
| Dec 1995 | $35.00M(-33.2%) | $8.50M(-1.2%) |
| Sep 1995 | - | $8.60M(-3.4%) |
| Jun 1995 | - | $8.90M(-1.1%) |
| Mar 1995 | - | $9.00M(-29.7%) |
| Dec 1994 | $52.40M(+6.1%) | $12.80M(+1.6%) |
| Sep 1994 | - | $12.60M(-7.4%) |
| Jun 1994 | - | $13.60M(+1.5%) |
| Mar 1994 | - | $13.40M(-68.5%) |
| Dec 1993 | $49.40M(+65.8%) | $42.60M(+1752.2%) |
| Sep 1993 | - | $2.30M(-79.3%) |
| Jun 1993 | - | $11.10M(-1.8%) |
| Mar 1993 | - | $11.30M(+34.5%) |
| Dec 1992 | $29.80M(+626.8%) | $8.40M(+5.0%) |
| Sep 1992 | - | $8.00M(+19.4%) |
| Jun 1992 | - | $6.70M(0.0%) |
| Mar 1992 | - | $6.70M(+857.1%) |
| Dec 1991 | $4.10M(+105.0%) | $700.00K(-65.0%) |
| Sep 1991 | - | $2.00M(+150.0%) |
| Jun 1991 | - | $800.00K |
| Dec 1990 | $2.00M | - |
FAQ
- What is Regeneron Pharmaceuticals, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. annual operating expenses year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
What is Regeneron Pharmaceuticals, Inc. annual total operating expenses?
The current annual operating expenses of REGN is $8.14B
What is the all time high annual operating expenses for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high annual total operating expenses is $8.14B
What is Regeneron Pharmaceuticals, Inc. annual operating expenses year-on-year change?
Over the past year, REGN annual total operating expenses has changed by +$1.07B (+15.16%)
What is Regeneron Pharmaceuticals, Inc. quarterly total operating expenses?
The current quarterly operating expenses of REGN is $1.92B
What is the all time high quarterly operating expenses for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high quarterly total operating expenses is $2.07B
What is Regeneron Pharmaceuticals, Inc. quarterly operating expenses year-on-year change?
Over the past year, REGN quarterly total operating expenses has changed by +$68.10M (+3.68%)